Atlas Trials

Sporadic Inclusion Body Myositis

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Sporadic Inclusion Body Myositis

RecordFirmDate
Sporadic Inclusion Body Myositis Natural History Study (NCT05046821)University of California, Irvine2021-10-11
Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis (NCT04421677)University of Kansas Medical Center2020-08-20
Safety and Efficacy of REGN2477+REGN1033 in Patients With Sporadic Inclusion Body Myositis (NCT03710941)Regeneron Pharmaceuticals2019-02-19
Pharmacoepidemiologic General Research Extension: PGRx-sIBM Study (NCT02735447)La-ser Europe Limited2016-05-01
An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 (NCT02573467)Novartis Pharmaceuticals2015-11-02
Blood-flow Restricted Exercise in Inclusion Body Myositis (NCT02317094)University of Southern Denmark2015-01-01
Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients (NCT01925209)Novartis Pharmaceuticals2013-09-26
Follistatin Gene Transfer to Patients With Becker Muscular Dystrophy and Sporadic Inclusion Body Myositis (NCT01519349)Nationwide Children's Hospital2012-01-01
Efficacy, Safety and Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis (NCT01423110)Novartis Pharmaceuticals2011-08-01

Track Sporadic Inclusion Body Myositis automatically

Every clearance here is in the API, with alerts when new ones post.